Envista(NVST)

Search documents
Envista(NVST) - 2023 Q3 - Earnings Call Transcript
2023-11-01 23:27
Orthodontic specialists continue to see the value of our comprehensive portfolio of solutions and are working hard to be the partner of choice for orthodontists worldwide. Envista Business System, EBS, drives the Spark growth formula and we are consistently adding new doctors, increasing case volume with the existing doctors and growing our revenue per case. Given our success today and our overall trajectory of Spark, we're now focused on delivering our next longterm growth milestone. By the end of 2026, we ...
Envista(NVST) - 2023 Q3 - Earnings Call Presentation
2023-11-01 23:16
Third Quarter 2023 2 Progress on Strategic Priorities 4 Adjusted EBITDA* $123.5M 5 Core Sales Growth* 0.8% − Western Europe delivered DD growth − Continue to invest in long-term growth initiatives • Orthodontics − Spark continues to outperform; Strong growth in Europe & North America • Implant-based Tooth Replacements 20.8% 19.7% • Profitability investments in Spark acceleration & other growth initiatives Adjusted Operating Profit Margin* Sales Adjusted Operating Margin ($ m) 26.1% 24.6% Q3 2022 Q3 2023 • P ...
Envista(NVST) - 2023 Q2 - Earnings Call Presentation
2023-08-03 03:36
Revenue Sales Adjusted Operating Margin ($ m) $245.4 $238.1 25.7% 21.7% − Restorative & Endodontics business grew strongly; Infection prevention − Continue to de-emphasize non-strategic solutions and geographies | --- | --- | --- | |-------------------------------|-------|-------| | Free Cash Flow** Summary ($M) | Q2'22 | Q2'23 | | Operating cash flow* | $22.2 | $75.1 | | Capital expenditures, net* | $10.4 | $14.1 | | Free cash flow*,** | $11.8 | $61.0 | • Free Cash Flow 8 Core Sales Growth and Adjusted EBI ...
Envista(NVST) - 2023 Q2 - Earnings Call Transcript
2023-08-03 03:36
Envista Holdings Corporation (NYSE:NVST) Q2 2023 Earnings Conference Call August 2, 2023 5:00 PM ET Company Participants Stephen Keller - Vice President, Investor Relations Amir Aghdaei - President and CEO Howard Yu - Chief Financial Officer Conference Call Participants Elizabeth Anderson - Evercore ISI Michael Cherny - Bank of America Jeff Johnson - Baird Brandon Couillard - Jefferies Jon Block - Stifel Jason Bednar - Piper Sandler Nathan Rich - Goldman Sachs Operator Hello. My name is Chelsea, and I will ...
Envista(NVST) - 2023 Q2 - Quarterly Report
2023-08-01 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________ FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39054 ENVISTA HOLDINGS CORPORATION (Exact name of Registrant as specified in its charter) | ...
Envista(NVST) - 2023 Q1 - Earnings Call Transcript
2023-05-04 03:35
Envista Holdings Corporation (NYSE:NVST) Q1 2023 Earnings Conference Call May 3, 2023 5:00 PM ET Company Participants Stephen Keller - VP, IR Amir Aghdaei - President and CEO Howard Yu - CFO Conference Call Participants Elizabeth Anderson - Evercore ISI Jeff Johnson - Baird Erin Wright - Morgan Stanley Jon Block - Stifel Michael Cherny - Bank of America Brandon Vazquez - William Blair Operator My name is David, and I will be your conference call facilitator this afternoon. At this time, I would like to welc ...
Envista(NVST) - 2023 Q1 - Quarterly Report
2023-05-02 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________ FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR Securities Registered Pursuant to Section 12(b) of the Act: | Title of each class | Trading symbol(s) | Name of each exchange on which registered | | --- | --- | --- | | Common stock, $0.01 par value | NVST | New York Stock Exchange | Indicate ...
Envista(NVST) - 2022 Q4 - Annual Report
2023-02-15 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________ FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39054 ENVISTA HOLDINGS CORPORATION (Exact name of registrant as specified in its charter) (Stat ...
Envista(NVST) - 2022 Q4 - Earnings Call Presentation
2023-02-09 00:37
Fourth Quarter 2022 Earnings Presentation February 8, 2023 Forward Looking Statements Q4 2022: Financial Metrics Certain statements in this press release are "forward-looking" statements within the meaning of the federal securities laws. There are a number of important factors that could cause actual results, developments and business decisions to differ materially from those suggested or indicated by such forward-looking statements and you should not place undue reliance on any such forward-looking stateme ...
Envista(NVST) - 2022 Q4 - Earnings Call Transcript
2023-02-09 00:36
Financial Data and Key Metrics Changes - For the full year 2022, core sales growth was up 4.1% with an adjusted EBITDA margin of 20.1%, representing a 40 basis point expansion over 2021 [8][24] - Fourth quarter sales increased 1.4% to $660.8 million, with core sales growth of 2.3% compared to Q4 2021 [30][33] - Adjusted EPS for Q4 was $0.52, a 13% increase year-over-year from $0.46 [33] Business Line Data and Key Metrics Changes - The orthodontics business saw over 15% core growth in 2022, driven by the Spark aligner system [16][34] - Specialty Products and Technology segment had a core revenue increase of 4.5% in Q4, while the Equipment and Consumables segment saw a 0.9% decline [33][37] - The implant-based tooth replacement business experienced solid mid-single-digit core growth in 2022, despite declines in China and Russia [22][35] Market Data and Key Metrics Changes - Developed markets grew 3.5%, with strong growth in Western Europe, while China and Russia saw significant declines [31] - Emerging markets grew low-single-digits, with China and Russia experiencing double-digit declines in Q4 [31][34] - The adjusted gross margin for Q4 was 56.2%, a decrease of 90 basis points year-over-year, primarily due to inflation and strong growth of Spark [31] Company Strategy and Development Direction - The company aims to accelerate growth, expand operating margins, and transform its portfolio through disciplined capital deployment [49][50] - The focus remains on being a leader in orthodontics and implant-based tooth replacement, leveraging premium offerings and digital capabilities [50][51] - The company is committed to continuous improvement and customer-centric culture, utilizing the Envista Business System (EBS) to drive productivity and operational efficiency [14][52] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the long-term growth prospects of the dental market, despite short-term headwinds from economic uncertainties and geopolitical risks [11][46] - For 2023, the company expects low-single-digit core growth and adjusted EBITDA margins over 20%, with an anticipated acceleration in growth as China stabilizes [47][48] - Management highlighted the importance of monitoring patient traffic and appointment bookings, indicating resilience in patient demand but acknowledging potential volatility [12][46] Other Important Information - The company generated free cash flow of $95.1 million in Q4 and ended the year with over $600 million in cash [42][43] - Significant investments were made in long-term growth initiatives, with a focus on optimizing organizational structure to improve customer experience [25][43] Q&A Session All Questions and Answers Question: Health of the dental consumer in the U.S. and Europe - Management noted that patient demand remains resilient, with consistent bookings and patient traffic in specialty businesses, despite challenges in China and Russia [56] Question: Magnitude of VBP headwinds on EBITDA margin - Management indicated that VBP is expected to have a headwind of about 35% on pricing, which will likely be dilutive for the duration of 2023 [61][64] Question: Underlying trends in the first quarter - Management reported continued expansion of the Spark business and solid performance in implant sales outside China and Russia, while noting challenges in those regions [70][72] Question: European growth sustainability - Management expressed confidence in sustained growth in Western Europe due to systematic execution and strong relationships with orthodontists, beyond just DSO wins [81][87] Question: Share gains versus pricing in consumables - Management highlighted that the growth in the consumables business is driven by both share gains and targeted pricing strategies, with expectations for continued mid-single-digit to high-single-digit growth [92]